semaglutide europe Weight loss drugs like Ozempic not linked with suicidal thoughts, EU drugs regulator finds – POLITICO European Commission approves more effective

Semaglutide is a once-weekly injectable medication that works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1) that regulates appetite and blood sugar levels

Tirzepatide is administered as a once-weekly subcutaneous injection, with a recommended starting dose of 2.5 mg once weekly for 4 weeks, then increasing by 2.5 mg every 4 weeks until the target dose (up to 15 mg) is reached

Instead, here are the basic tenets of a healthy, nutritious eating plan on a GLP-1: Prioritize protein : Protein helps maintain muscle mass, which is especially important when youre losing weight

Gradual tapering (reducing dose over 48 weeks) is gentler on appetite regulation than stopping abruptly